Influenza News and Research

Latest Influenza News and Research

Researchers explore nanotechnology’s potential to deliver synergistic therapeutics for COVID-19

A team of scientists reviewed the nanoencapsulation approaches of synergistic compounds (Lectins, Caffeine, Cocoa, Flavonoids, Quercetin) and the role of nanotechnology in addressing the COVID-19 pandemic.

19 Mar 2021

Engineering immunogens to focus immune response to SARS-CoV-2

Researchers have designed constructs by adding more glycans and adding the receptor-binding motif from related sarbecoviruses to focus the immune response to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) receptor-binding motif. Such immunogens could potentially also neutralize other variants and coronaviruses.

18 Mar 2021

UK SARS-CoV-2 variant 40% more transmissible than previous strains

Researchers in Japan have estimated that the B.1.1.7 strain of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that recently emerged in England is 40% more transmissible than strains previously circulating in the country.

18 Mar 2021

Study reveals unknown immune defense system that protects the lungs from viral infections

Researchers have uncovered a previously unknown arm of the immune defence system that protects the lung from lethal viral infections.

18 Mar 2021

The role of S-acylation in the enhancement of SARS-CoV-2 infectivity

A new study published on the bioRxiv server focuses on the role of S-acylation in the SARS-CoV-2 infection cycle. It has also characterized Spike acylation and has also identified other acylated viral proteins and host enzymes involved in the process of infection. Further, it has also revealed the importance of acylation in viral biogenesis and infection.

18 Mar 2021

Microbiota modulation and re-establishment of eubiosis could help curb COVID-19 complications

In the paper published in the journal Frontiers in Immunology, the researchers noted that since both the respiratory tract and the gastrointestinal mucosa are affected in COVID-19, it is possible that adjunctive therapies that modulate the gut-lung axis.

18 Mar 2021

Coronaviruses may be vulnerable to ultrasound vibrations, study suggests

The coronavirus' structure is an all-too-familiar image, with its densely packed surface receptors resembling a thorny crown.

17 Mar 2021

Could visible light be a safe and effective SARS-CoV-2 disinfectant?

A new study reports that blue light with a wavelength of 400–420 nm can inactivate enveloped viruses like SARS-CoV-2 and influenza. This could allow continuous disinfection of spaces even when people are present.

17 Mar 2021

Can vaccination and infection rates add up to reach Covid herd immunity?

It's been a long, dark winter of Covid concerns, stoked by high post-holiday case counts and the American death tally exceeding 530,000 lives lost.

17 Mar 2021

Socioeconomic disparities could explain the association of race/ethnicity with worse COVID-19 outcomes

A new study published online in the Annals of the American Thoracic Society reveals how socioeconomic factors partially explain the increased odds that Black and Hispanic Americans have of testing positive for SARS-CoV-2, the virus that causes COVID-19.

17 Mar 2021

Researchers develop innovative profiling methods for SARS-CoV-2 infection

A team of researchers from various institutions in the USA used RNA-sequencing data and other methods to profile unique genes and other characteristics associated with SARS-CoV-2 in New York City (NYC).

17 Mar 2021

Living with a COVID-19 case brings worse symptoms and stronger antibody response

This study suggests that high virus exposure levels contribute to greater disease severity and stronger antibody responses. The observations from this study are published on the medRxiv preprint server.

17 Mar 2021

Using iodine as catalyst to advance the sustainability of pharmaceutical syntheses

Synthesizing pharmaceuticals for cancer, viral diseases, and other medical conditions is slow work. A particularly challenging chemical transformation is to start with what's known as an unactivated alkene--a common molecular building block--and end up with a vicinal diamine; i.e., installation of two nitrogen units into carbon--carbon double bonds.

16 Mar 2021

Combination therapy may reduce influenza-associated morbidity and mortality

A significant proportion of hospitalized patients with influenza develop complications of acute respiratory distress syndrome, driven by virus-induced cytopathic effects as well as exaggerated host immune response.

16 Mar 2021

Ferret study shows SARS-CoV-2 airborne transmission dynamics

A team of researchers led by Sander Herfst from Erasmus University Medical Center in The Netherlands suggests severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) could spread through the air at a one-meter distance and cause infection in a new ferret model study.

16 Mar 2021

Cross-national study associates low vitamin D levels with higher COVID-19-related mortality

A new study by an international team of researchers – from New York University, Abu Dhabi, the Ludwig-Maximilians-Universität, München, and Barts Cancer Institute, London – showed that there are lower COVID-19 mortality rates in countries with the most insufficient annual sun exposure, but highest mean 25-hydroxyvitamin D (25(OH)D) or vitamin D (25)-HD levels.

16 Mar 2021

An increase in the risk of clinical sequelae after SARS-CoV-2 infection

A new piece of research, published on the medRxiv preprint server, focused on the role of factors such as gender, age, hospitalization, etc., in understanding the risks of clinical sequelae in the post-acute phase of COVID-19, in adults aged between 18 and 65 years.

15 Mar 2021

What is a protective neutralizing antibody titer against SARS-CoV-2 infection?

A new study describes a predictive model of protective immunity against SARS-CoV-2 infection that could help evolve optimal vaccination strategies to maintain protection and reduce the death rate.

15 Mar 2021

New vaccination method aims at comprehensive protection against all known influenza mutations

One shot, protected forever: This would be a dream come true regarding influenza vaccinations. So far, vaccination against influenza did not provide a lasting protection.

13 Mar 2021

SARS-CoV-2 did not change much when it jumped from bats to human hosts

How much did SARS-CoV-2 need to change in order to adapt to its new human host? In a research article published in the open access journal PLOS Biology Oscar MacLean, Spyros Lytras at the University of Glasgow, and colleagues, show that since December 2019 and for the first 11 months of the SARS-CoV-2 pandemic there has been very little 'important' genetic change observed in the hundreds of thousands of sequenced virus genomes.

13 Mar 2021

Influenza News and Research

Latest Influenza News and Research

Researchers explore nanotechnology’s potential to deliver synergistic therapeutics for COVID-19

Engineering immunogens to focus immune response to SARS-CoV-2

UK SARS-CoV-2 variant 40% more transmissible than previous strains

Study reveals unknown immune defense system that protects the lungs from viral infections

The role of S-acylation in the enhancement of SARS-CoV-2 infectivity

Microbiota modulation and re-establishment of eubiosis could help curb COVID-19 complications

Coronaviruses may be vulnerable to ultrasound vibrations, study suggests

Could visible light be a safe and effective SARS-CoV-2 disinfectant?

Can vaccination and infection rates add up to reach Covid herd immunity?

Socioeconomic disparities could explain the association of race/ethnicity with worse COVID-19 outcomes

Researchers develop innovative profiling methods for SARS-CoV-2 infection

Living with a COVID-19 case brings worse symptoms and stronger antibody response

Using iodine as catalyst to advance the sustainability of pharmaceutical syntheses

Combination therapy may reduce influenza-associated morbidity and mortality

Ferret study shows SARS-CoV-2 airborne transmission dynamics

Cross-national study associates low vitamin D levels with higher COVID-19-related mortality

An increase in the risk of clinical sequelae after SARS-CoV-2 infection

What is a protective neutralizing antibody titer against SARS-CoV-2 infection?

New vaccination method aims at comprehensive protection against all known influenza mutations

SARS-CoV-2 did not change much when it jumped from bats to human hosts

This International Women’s Day, Meet the Scientist Changing Women’s Healthcare

Microphysiological systems in drug discovery

Considerations for taking ASO discovery programs into animal models

Influenza News and Research

Latest Influenza News and Research

This International Women’s Day, Meet the Scientist Changing Women’s Healthcare

Microphysiological systems in drug discovery

Considerations for taking ASO discovery programs into animal models

Newsletters you may be interested in